Drugs & medicalClass II

Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA,…

Presence of Particulate Matter.

Read the official notice →
Date
2026-01-21
Country
United States
Brand
Cipla
Product
Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA,…
Classification
Class II
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Cipla recalls

  1. 2026-04-15
  2. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen…

    Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

    FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
  3. 2026-03-11
  4. US
    Drugs & medicalClass III

    Cipla USA, Inc. recalls Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for:…

    Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

    FDA · DrugCipla USA, Inc.U.S.A. NationwideOfficial notice →
  5. 2026-01-28
  6. US
  7. 2025-12-17
  8. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard,…

    CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

    FDA · DrugCipla USA, Inc.Nationwide in the USOfficial notice →
  9. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals,…

    Failed stability specifications: Out of specification for hardness test

    FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
  10. 2025-12-10
  11. US
    Drugs & medicalClass II

    Cipla Limited recalls Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule…

    Failed Stability Specifications: Observed OOS results: eg results for colour index

    FDA · DrugCipla LimitedNationwide in the USAOfficial notice →
All 20 Cipla recalls →

Other drugs & medical recalls in the United States

  1. 2026-01-21
  2. US
    Drugs & medicalClass II

    REPLIGEN CORPORATION recalls MAVERICK¿ Measurement Module Spectrometer PN 820-01367 (originally part of a kit PN 820-01519) Finished Goods PN 820-01496

    Potential Elevated Laser Output A disconnected cable or a poorly crimped cable under mechanical bending stress can cause loss of electrical contact. At one connection on the board, the failure can drive the laser…

    FDA · DeviceREPLIGEN CORPORATIONU.S.Official notice →
  3. US
    Drugs & medicalClass I

    Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3…

    Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results

    FDA · DeviceAbbott Diabetes Care, Inc.U.S.: AK, AL, AZ, CA, CO, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, MI, MN, MO,…Official notice →
  4. US
    Drugs & medicalClass II

    Canon Medical System, USA, INC. recalls VANTAGE GALAN 3T Model MRT-3020/MEXL-3020

    There is a potential for formation of ice occurring in the venting system of the superconducting magnet of the MRI systems. if a quench occurs in this condition, helium gas may not be able to escape via the designed…

    FDA · DeviceCanon Medical System, USA, INC.U.S. Nationwide distribution in the states of CA, CO, FL, IA, IL, IN, KS, MD,…Official notice →
  5. US
    Drugs & medicalClass II

    GOLD STAR DISTRIBUTION INC recalls TYLENOL a) 500 MG., 2'S DISPLAY, 50CT; b) COLD & FLU, 25CT/2S; c) COLD & FLU SEVERE, 2PK, 50CT; d) PM, 50CT; e) SINUS SEVERE, 2PK, 50CT

    CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

    FDA · DrugGOLD STAR DISTRIBUTION INCUS Nationwide.Official notice →
  6. US
    Drugs & medicalClass II

    Encon Safety Products Co recalls AQ 120 GFEW, Aquarion Preserved Cartridges (2) 3.7 Gallons each

    cGMP deviations.

    FDA · DrugEncon Safety Products CoNationwide within the United StatesOfficial notice →
  7. US
    Drugs & medicalClass II

    Alvogen, Inc recalls Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA,…

    Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

    FDA · DrugAlvogen, IncUS Nationwide.Official notice →
See all drugs & medical recalls →